Medical device establishment licence changes

Summary#

These are the final Regulations Amending the Medical Devices Regulations (Establishment Licences). They change who must hold a medical device establishment licence (MDEL), require licence applicants and holders to give supplier details, and make certain record-keeping and procedure requirements explicit. The rules come into force on the 180th day after registration (registration: June 4, 2026).

What it does#

• Removes the automatic requirement that a foreign distributor hold an MDEL when a Canadian importer already holds one.
  • Retailers and health care facilities that do not hold an MDEL still must import only from someone who does.
• Requires every MDEL applicant and holder to provide, and update annually, supplier information. That includes:
  • the name and address of any person (other than the manufacturer) who sells devices to the establishment; and
  • the class(es) of devices those suppliers sell to the establishment.
• Makes explicit that manufacturers, importers and distributors must each establish, implement and maintain documented procedures for:
  • maintaining distribution records;
  • incident reporting and providing information about serious health risks;
  • handling, storage, delivery, installation, servicing and corrective action (for Class II, III and IV devices where applicable);
  • making preliminary and final incident reports, as required.
• Changes some application and annual-review rules, including a requirement that licence-holders submit annual review material before April 1 each year.
• Adds a transitional rule: MDEL applications already being processed when the amendments come into force must provide the new supplier information before a licence is issued.

Who's affected#

• Health Canada (the regulator) will collect and use more supplier information and adjust oversight and inspections.
• Canadian importers and distributors who hold or apply for an MDEL. They must supply and update supplier lists and keep the documented procedures described above.
• Foreign distributors: some will no longer need an MDEL when they sell only to a licensed Canadian importer.
• Manufacturers, especially makers of Class II, III and IV devices, who must have or confirm documented procedures (many already do through existing quality systems).
• Retailers and health care facilities that do not hold an MDEL — they still must import from licensed suppliers.
• Small businesses: about half of current MDEL holders are small firms. Health Canada estimates some of the administrative costs will fall on small businesses.

Why it matters#

• It reduces a duplicate licensing step for foreign distributors selling only through licensed Canadian importers. That may make it easier and cheaper for some suppliers to sell to Canada and could increase options for buyers here.
• It gives Health Canada clearer visibility of who supplies medical devices in Canada. That should help trace problems faster in recalls and safety investigations.
• It makes explicit that companies must have written, maintained procedures for key safety tasks. That aims to fix gaps inspectors found and improve how quickly problems are detected and managed.
• There are small administrative costs to industry and government. Health Canada estimates total monetized costs of about $1.8 million (present value) over 10 years, and estimates benefits to foreign MDEL holders of about $2.3 million (present value) over 10 years (the latter is not counted in Canada’s cost–benefit totals).
• If you are an affected business with an MDEL application in progress, be prepared to provide supplier information before a licence will be issued.